Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus ErythematosusArthritis Rheumatol 2022 Jan 01;74(1)112-123, E Ginzler, LS Guedes Barbosa, D D'Cruz, R Furie, K Maksimowicz-McKinnon, J Oates, MB Santiago, A Saxena, S Sheikh, DL Bass, SW Burriss, JA Gilbride, JG Groark, M Miller, A Pierce, DA Roth, B Ji
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.